This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Biologicals S.a.. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: The Innovations of Jean Petre
Introduction
Jean Petre is a notable inventor based in Belgium, recognized for his contributions to vaccine development. His work focuses on creating stable and effective multivalent vaccine compositions, particularly those that include the Hepatitis B surface antigen (HBsAg).
Latest Patents
Jean Petre holds 1 patent for a vaccine that describes stable and effective multivalent vaccine compositions comprising HBsAg. This innovative vaccine formulation ensures that the HBsAg component remains stable for one week at 37°C and is highly immunogenic, especially when administered to infants. The compositions typically include HBsAg adsorbed to aluminium phosphate along with other antigens suitable for pediatric use. Additionally, methods for preparing these vaccines and the use of aluminium phosphate to stabilize HBsAg in multivalent formulations are also detailed in his patent.
Career Highlights
Jean Petre has made significant strides in the field of immunology through his work at SmithKline Beecham Biologicals. His research has contributed to advancements in vaccine technology, particularly in enhancing the stability and efficacy of vaccines for young children.
Collaborations
Jean Petre has collaborated with Pierre Hauser, furthering the development of innovative vaccine solutions.
Conclusion
Jean Petre's work exemplifies the importance of innovation in vaccine development, particularly in creating formulations that are both stable and effective for pediatric use. His contributions continue to impact the field of immunology positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile